Prescription medication · Systemic Retinoid
isotretinoin
Also sold as Accutane, Absorica. Isotretinoin capsules treat severe nodular acne.
Data updated 2026-05-15
- 47,513
- FDA reportsOften reported
- 7
- InteractionsFew interactions
- 95% less
- Generic vs brandHuge savings
- 5
- Recall records
What the data shows
isotretinoin (Accutane) is a prescription Systemic Retinoid, reported at a middle-of-the-pack volume (47,513 FDA reports), whose generic costs a fraction of the brand (about 95% less).
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
isotretinoin (Accutane) is a prescription Systemic Retinoid. Isotretinoin capsules treat severe nodular acne.
Isotretinoin capsules are a strong medicine used to treat severe acne. It helps clear up acne when other treatments haven't worked.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Brand Price
$35.67/unit
Generic Price
$1.69/unit
Generic Savings
95%
Generic Available
Yes (13 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
Isotretinoin capsules treat severe nodular acne.
Common side effects
Dry skin, Dry lips, Dry nose
Key warnings
Isotretinoin capsules can cause severe birth defects.
The sections below are summarized in plain English from isotretinoin's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Isotretinoin is related to vitamin A. It works by reducing the amount of oil released by oil glands in your skin. It also helps to reduce inflammation and prevent clogged pores.
Side Effects (from patient reports)
Based on 47,513 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for isotretinoin, by number of reports
- Depression
Depression
5,699 reports
- Inflammatory Bowel Disease
Inflammatory Bowel Disease
5,252 reports
- Colitis Ulcerative
Colitis Ulcerative
3,796 reports
- Dry Skin
Dry Skin
2,325 reports
- Suicidal Ideation 2,113
Suicidal Ideation
2,113 reports
- Pregnancy 2,074
Pregnancy
2,074 reports
- Irritable Bowel Syndrome 2,015
Irritable Bowel Syndrome
2,015 reports
- Headache 1,943
Headache
1,943 reports
- Arthralgia 1,909
Arthralgia
1,909 reports
- Anxiety 1,884
Anxiety
1,884 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Reports over time
Adverse-event reports filed for isotretinoin each year to the FDA Adverse Event Reporting System (FAERS).
Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.
Where isotretinoin sits
isotretinoin has more FDA adverse-event reports than 72% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.
Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is isotretinoin; the line is the median (50th percentile).
FDA Adverse Event Report Analysis
Detailed analysis of 47,513 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2000–2025.
Total Reports
47,513
Reports Mentioning Death
878
1.8% of reports — not proof of cause
Hospitalization Reports
4,281
Top Indication
Acne
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 1 | DEPRESSION | 5,699 |
| 2 | INFLAMMATORY BOWEL DISEASE | 5,252 |
| 3 | COLITIS ULCERATIVE | 3,796 |
| 4 | DRY SKIN | 2,325 |
| 5 | SUICIDAL IDEATION | 2,113 |
| 6 | PREGNANCY | 2,074 |
| 7 | IRRITABLE BOWEL SYNDROME | 2,015 |
| 8 | HEADACHE | 1,943 |
| 9 | ARTHRALGIA | 1,909 |
| 10 | ANXIETY | 1,884 |
| 11 | UNINTENDED PREGNANCY | 1,882 |
| 13 | CROHN^S DISEASE | 1,676 |
| 14 | EXPOSURE DURING PREGNANCY | 1,584 |
| 15 | LIP DRY | 1,534 |
| 16 | ADVERSE DRUG REACTION | 1,439 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
Isotretinoin capsules can cause severe birth defects. You must not take this medicine if you are pregnant or may become pregnant. You must use two forms of birth control while taking isotretinoin capsules. If you get pregnant while taking isotretinoin capsules, stop taking it right away and see a doctor.
Known Drug Interactions
Micro-dosed Progesterone Preparations: Micro-dosed progesterone preparations ("minipills" that do not contain an estrogen) may be an inadequate method of contraception during isotretinoin capsules therapy. Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum ® 7/7/7 Tablets as an oral contraceptive agent, isotretinoin capsules at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of...
Mechanism: This drug can interfere with 'mini-pills' that only contain progesterone, making them less reliable for preventing pregnancy.
Drug Interactions Vitamin A: Because of the relationship of isotretinoin capsules to vitamin A, patients should be advised against taking vitamin supplements containing vitamin A to avoid additive toxic effects.
Mechanism: Both of these are forms of Vitamin A, and taking them together can cause the vitamin to build up to toxic levels.
Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum ® 7/7/7 Tablets as an oral contraceptive agent, isotretinoin capsules at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).
Mechanism: Studies show that isotretinoin does not change the levels of estradiol in your body. It does not interfere with how this hormone is processed.
Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum ® 7/7/7 Tablets as an oral contraceptive agent, isotretinoin capsules at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).
Mechanism: Isotretinoin does not affect the amount of norethindrone in your blood or how well it works. It does not seem to change the effectiveness of this hormone.
Phenytoin : Isotretinoin capsules have not been shown to alter the pharmacokinetics of phenytoin in a study in seven healthy volunteers. Phenytoin is known to cause osteomalacia. No formal clinical studies have been conducted to assess if there is an interactive effect on bone loss between phenytoin and isotretinoin capsules.
Mechanism: Both drugs may have an effect on bone strength, though it is not certain if taking them together increases the risk of bone loss.
This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.
Common Questions
Can I take vitamin A supplements while taking isotretinoin capsules?
Can I donate blood while taking isotretinoin capsules?
What should I do if I experience depression while taking isotretinoin capsules?
Can I have laser treatments or waxing while taking isotretinoin capsules?
How often will I see my doctor while taking isotretinoin capsules?
Can I drink alcohol while taking isotretinoin capsules?
What is the iPLEDGE program?
How long does it take for isotretinoin capsules to work?
What happens if I stop taking isotretinoin capsules early?
Can isotretinoin capsules cure my acne?
What are the common side effects of isotretinoin?
Does isotretinoin interact with other medications?
What drug class is isotretinoin?
Is there a generic version of isotretinoin?
What pregnancy or breastfeeding source fields are listed for isotretinoin?
Has isotretinoin been recalled?
Active Recalls
Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin
Teva Pharmaceuticals USA, Inc
Failed Dissolution Specifications
MYLAN PHARMACEUTICALS INC
Superpotent and Subpotent
Teva Pharmaceuticals USA, Inc
Superpotent and Subpotent
Teva Pharmaceuticals USA, Inc
Superpotent Drug: The 3-month stability result for assay was found to be above specification limit
Teva Pharmaceuticals USA, Inc
Related Medications in Systemic Retinoid
Other drugs grouped near isotretinoin - same-class peers and common alternatives.
adapalene
Differin
Compare with isotretinoin →
apremilast
Otezla
Apremilast (Otezla/Otezla XR) is a medicine that can help adults and children manage psoriatic arthritis and psoriasis.
Compare with isotretinoin →
azelaic acid
Finacea, Azelex
Azelaic acid gel is a topical medicine that helps treat rosacea.
Compare with isotretinoin →
benzoyl peroxide
Benzac, PanOxyl
Benzoyl peroxide is a topical medicine that fights germs on your skin.
Compare with isotretinoin →
betamethasone
Diprosone, Luxiq
Betamethasone dipropionate cream is a strong steroid medicine used on the skin.
Compare with isotretinoin →
Compare beyond drug class
Nationwide peers by FAERS volume & death-report share
Two PlainMeds-derived comparison paths for isotretinoin: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.
Similar FAERS report volume
Nearest drugs by total FAERS reports. This record: 47,513.
Similar death-report share
Nearest drugs by FAERS death-report share. This record: 1.85%.
- dulaglutide Δ 0.00 pts · 85,635 reports · GLP-1 Receptor Agonist 1.85%death share
- lifitegrast Δ 0.05 pts · 15,783 reports · LFA-1 Antagonist (Ophthalmic) 1.79%death share
- estradiol Δ 0.08 pts · 83,781 reports · Estrogen Hormone 1.77%death share
- calcipotriene Δ 0.11 pts · 3,344 reports · Vitamin D Analog (Topical) 1.73%death share
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on isotretinoin
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for isotretinoin
The FDA label for isotretinoin (sold under brand names such as Accutane, Absorica) classifies it as a prescription-only medication in the Systemic Retinoid class. Isotretinoin capsules treat severe nodular acne. Official labeling lists 4 commonly reported side effects, including Dry skin, Dry lips, Dry nose.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 47,513 voluntary reports. The database also lists 7 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS shows a generic unit cost of $1.69 versus $35.67 for the brand - a 95% generic savings.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 5 recall records on file), and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: June 26, 2024
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages